Kinnate BiopharmaKNTE
13F holders, Q1 2024 (March 31)56holders
4famous investors
$2.66avg. 13F price*
At the end of Q1 2024, 56 institutions reported holding Kinnate Biopharma Inc. (KNTE) in their 13F filings. The largest holders were Foresite Capital Management IV, LLC ($25.7M), Orbimed Advisors LLC ($21.3M) and Foresite Capital Management V, LLC ($9.4M). 4 famous investors held it, including Andreas Halvorsen (0.0% of Viking Global Investors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Kinnate Biopharma Inc.
- CUSIP
- 49705R105
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $5.3M |
| Exits | 20 | $9.2M |
Ownership 56 holders
| Foresite Capital Management IV, LLC | 13.00% | No change | 9,671,643 | $25.7M |
| Orbimed Advisors LLC | 0.39% | No change | 8,009,729 | $21.3M |
| Foresite Capital Management V, LLC | 8.80% | No change | 3,525,957 | $9.4M |
| Lynx1 Capital Management LP | 1.36% | Reduce -0.8% | 1,981,106 | $5.3M |
| Viking Global Investors | 0.02% | No change | 1,820,462 | $4.8M |
| Vanguard Group Inc. | 0.00% | Add +3.3% | 1,076,789 | $2.9M |
| Deltec Asset Management LLC | 0.55% | New | 1,039,800 | $2.8M |
| Tang Capital Management LLC | 0.27% | Reduce -62.4% | 977,626 | $2.6M |
| Acadian Asset Management LLC | 0.01% | Add +16.2% | 964,881 | $2.6M |
| Renaissance Technologies | 0.00% | Add +54.4% | 887,740 | $2.4M |
| Susquehanna International Group, LLP | 0.00% | Add +71.9% | 526,021 | $1.4M |
| BML Capital Management, LLC | 0.89% | Add +6.5% | 498,851 | $1.3M |
| Yakira Capital Management, Inc. | 0.46% | New | 496,840 | $1.3M |
| BlackRock Inc. | 0.00% | Reduce -26.5% | 431,406 | $1.1M |
| Group One Trading LLC | 0.03% | Reduce -37.2% | 354,121 | $942K |
| Gsa Capital Partners LLP | 0.07% | Reduce -1.3% | 334,694 | $890K |
| Millennium Management | 0.00% | Reduce -52.7% | 267,355 | $711K |
| Geode Capital Management, LLC | 0.00% | Add +5.8% | 244,151 | $650K |
| Citadel Advisors | 0.00% | Reduce -48.4% | 214,664 | $571K |
| Marshall Wace, LLP | 0.00% | Reduce -19.7% | 156,089 | $415K |
| Trium Capital LLP | 0.12% | New | 117,456 | $312K |
| Deutsche Bank AG | 0.00% | No change | 114,846 | $305K |
| XTX Topco Ltd | 0.04% | Add +69.9% | 104,437 | $278K |
| Equitec Proprietary Markets, LLC | 0.49% | New | 103,000 | $274K |
| Dimensional Fund Advisors LP | 0.00% | Add +530.2% | 91,961 | $245K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -59.6% | 63,090 | $168K |
| GTS Securities LLC | 0.00% | New | 60,038 | $160K |
| Skandinaviska Enskilda Banken AB (publ) | 0.00% | New | 51,200 | $136K |
| Susquehanna Portfolio Strategies, LLC | 0.00% | No change | 48,500 | $129K |
| Jane Street Group, LLC | 0.00% | Reduce -45.1% | 42,378 | $113K |
| Jefferies Financial Group Inc. | 0.00% | No change | 40,500 | $108K |
| State Board of Administration of Florida Retirement System | 0.00% | New | 14,254 | $89K |
| Northern Trust Corp. | 0.00% | No change | 27,778 | $74K |
| Cowen and Company, LLC | 0.00% | New | 25,000 | $67K |
| JPMorgan Chase & Co. | 0.00% | Add +39139.7% | 24,721 | $66K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 11,200 | $63K |
| Squarepoint Ops LLC | 0.00% | Reduce -60.6% | 23,187 | $62K |
| Simplex Trading, LLC | 0.00% | Reduce -50.9% | 21,764 | $57K |
| Occudo Quantitative Strategies LP | 0.01% | Reduce -70.0% | 20,925 | $56K |
| SG Americas Securities, LLC | 0.00% | New | 20,819 | $55K |
| BBR Partners, LLC | 0.00% | No change | 20,000 | $53K |
| Shay Capital LLC | 0.02% | New | 19,411 | $52K |
| Barclays PLC | 0.00% | Reduce -2.6% | 14,185 | $38K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Add +540.7% | 14,095 | $37K |
| Virtu Financial LLC | 0.00% | New | 11,445 | $30K |
| Morgan Stanley | 0.00% | Add +29.8% | 7,427 | $20K |
| Qube Research & Technologies Ltd | 0.00% | Add +1900.6% | 6,262 | $17K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -67.3% | 4,102 | $11K |
| Rhumbline Advisers | 0.00% | No change | 2,933 | $8K |
| Bank of America Corp. | 0.00% | Reduce -68.8% | 1,800 | $5K |
| Catalyst Funds Management Pty Ltd | 0.00% | — | 1,570 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -89.7% | 1,091 | $3K |
| UBS Group AG | 0.00% | Reduce -83.9% | 818 | $2K |
| CSS LLC | 0.00% | New | 584 | $2K |
| Wells Fargo & Company | 0.00% | Add +2.1% | 144 | $383 |
| Royal Bank of Canada | 0.00% | Add +366.7% | 14 | $0 |
"% of holder's portfolio" is KNTE's weight in each manager's 13F, not the share of Kinnate Biopharma Inc. the manager owns.